Table 4 KEGG pathway analysis of lncRNA oebiotech_11933 co-expression genes
From: Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes
Term | Count | % | P-value |
|---|---|---|---|
hsa04060:Cytokine-cytokine receptor interaction | 20 | 0.47 | 2.58E-04 |
hsa04010:MAPK signaling pathway | 15 | 0.35 | 0.02771 |
hsa04062:Chemokine signaling pathway | 14 | 0.33 | 0.003659 |
hsa04621:NOD-like receptor signaling pathway | 9 | 0.21 | 4.56E-04 |
hsa04620:Toll-like receptor signaling pathway | 7 | 0.16 | 0.080742 |
hsa04920:Adipocytokine signaling pathway | 6 | 0.14 | 0.048983 |
hsa05219:Bladder cancer | 5 | 0.12 | 0.035633 |